There’s some promising news for people living with myelodysplastic syndrome (MDS) as a new treatment option may reduce the ...

Vevoctadekin is under clinical development by Simcha Therapeutics and currently in Phase I for Myelodysplastic Syndrome.

Trecondyv is under clinical development by medac and currently in Pre-Registration for Myelodysplastic Syndrome.